The effect of Arnigol cream on pain intensity caused by needles in hemodialysis patients
Phase 2
- Conditions
- Chronic renal failure.Chronic kidney disease, stage 5
- Registration Number
- IRCT2016112615965N8
- Lead Sponsor
- Rafsanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 71
Inclusion Criteria
Patients were included if they were receiving hemodialysis through arteriovenous fistula at least two times a week for three consecutive months, were fully conscious, aged eighteen or more, did not suffer from neuropathies or peripheral vascular problems, had no sign of inflammation at fistula site, received no topical analgesic at fistula site prior to the study intervention, and had no known allergy to Arnigol cream. Exclusion criteria: Unsuccessful puncture at the first attempt and participants’ voluntary withdrawal from the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: Immediately after entering needles. Method of measurement: Based on a numerical scale VAS.
- Secondary Outcome Measures
Name Time Method